RecruitingNCT04583800

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes : Longitudinal Cohort Study of Immuno-inflammation, Cardiac Energetics and Cognition.PreciDIAB-HEART&BRAIN


Sponsor

University Hospital, Lille

Enrollment

600 participants

Start Date

Jun 22, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Type 2 diabetes is a risk factor of heart failure and cognitive decline. Heart failure at its early stage is often silent. At present, primary prevention for heart failure is not available. Our aim is to identify diabetic patients at risk of heart failure in order to develop personalized preventive strategies. Type 2 diabetes is vascular and metabolic risk factor for cognitive decline though a direct lesional effect but also through an interaction with underlying neurodegenerative lesions. Our aim is to identify diabetic patients at risk of cognitive decline in order to develop personalized preventive strategies


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Adults
  • Persons able to understand and object to the information provided.
  • Type 2 diabetic patient free of heart failure ≥stade B
  • Patient affiliated with a social security scheme.
  • Patient agreeing to sign the informed consent form

Exclusion Criteria2

  • Patient with dementia
  • Patient with at least one of the criteria for heart failure ≥stade B

Locations(1)

Hopital Roger Salengro, CHU Lille

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04583800


Related Trials